These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies. De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690 [TBL] [Abstract][Full Text] [Related]
23. Inflammatory muscle disease - An update. Baig S; Paik JJ Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904 [TBL] [Abstract][Full Text] [Related]
24. Peripheral T helper subset profiling in idiopathic inflammatory myositis: Proof of concept. Anuja AK; Mehta P; Singh MK; Singh H; Nath A; Hashim Z; Khan A; Gupta M; Misra DP; Agarwal V; Gupta L Reumatol Clin (Engl Ed); 2023 Mar; 19(3):143-149. PubMed ID: 36906390 [TBL] [Abstract][Full Text] [Related]
25. Pathology Features of Immune and Inflammatory Myopathies, Including a Polymyositis Pattern, Relate Strongly to Serum Autoantibodies. Pestronk A; Choksi R J Neuropathol Exp Neurol; 2021 Sep; 80(9):812-820. PubMed ID: 34363679 [TBL] [Abstract][Full Text] [Related]
26. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871 [TBL] [Abstract][Full Text] [Related]
27. High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis. Nakajima A; Yoshino K; Soejima M; Kawaguchi Y; Satoh T; Kuwana M; Yamanaka H Rheumatol Int; 2012 Jul; 32(7):2057-61. PubMed ID: 21479881 [TBL] [Abstract][Full Text] [Related]
28. Classification, diagnosis, and management of idiopathic inflammatory myopathies. Lazarou IN; Guerne PA J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386 [TBL] [Abstract][Full Text] [Related]
29. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets. Haq SA; Tournadre A Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431 [TBL] [Abstract][Full Text] [Related]
30. Aberrant expansion of circulating CD4 Zhang L; Li W; Cai Y; Liu X; Peng Q; Liang L Int J Rheum Dis; 2020 Mar; 23(3):397-405. PubMed ID: 31883219 [TBL] [Abstract][Full Text] [Related]
31. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires. Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700 [TBL] [Abstract][Full Text] [Related]
32. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies. de Padilla CM; Reed AM Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326 [TBL] [Abstract][Full Text] [Related]
33. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations. Ernste FC; Reed AM Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022 [TBL] [Abstract][Full Text] [Related]
34. Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients. Young-Glazer J; Cisneros A; Wilfong EM; Smith SA; Crofford LJ; Bonami RH Arthritis Res Ther; 2021 Jan; 23(1):33. PubMed ID: 33468230 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-35 in idiopathic inflammatory myopathies. Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920 [TBL] [Abstract][Full Text] [Related]
36. Evolving classification and role of muscle biopsy in diagnosis of inflammatory myopathies. Swain M; Uppin M Indian J Pathol Microbiol; 2022 May; 65(Supplement):S241-S251. PubMed ID: 35562156 [TBL] [Abstract][Full Text] [Related]
37. Adenosine A2B receptor activation regulates the balance between T helper 17 cells and regulatory T cells, and inhibits regulatory T cells exhaustion in experimental autoimmune myositis. Zhou Y; Kang L; Yin G; Yang L; Chen B; Liu B; Zhu X; Xie Q J Cachexia Sarcopenia Muscle; 2024 Dec; 15(6):2460-2475. PubMed ID: 39284778 [TBL] [Abstract][Full Text] [Related]
38. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Rothwell S; Cooper RG; Lundberg IE; Miller FW; Gregersen PK; Bowes J; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Hanna MG; Machado PM; Pachman LM; Reed AM; Rider LG; Cobb J; Platt H; Molberg Ø; Benveniste O; Mathiesen P; Radstake T; Doria A; De Bleecker J; De Paepe B; Maurer B; Ollier WE; Padyukov L; O'Hanlon TP; Lee A; Amos CI; Gieger C; Meitinger T; Winkelmann J; Wedderburn LR; Chinoy H; Lamb JA; Ann Rheum Dis; 2016 Aug; 75(8):1558-66. PubMed ID: 26362759 [TBL] [Abstract][Full Text] [Related]
39. Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ. Ghannam K; Martinez-Gamboa L; Spengler L; Krause S; Smiljanovic B; Bonin M; Bhattarai S; Grützkau A; Burmester GR; Häupl T; Feist E PLoS One; 2014; 9(8):e104048. PubMed ID: 25098831 [TBL] [Abstract][Full Text] [Related]